NR3C2 and neoplasm: Over-expression of circARHGAP10 or MR markedly induced the cisplatin sensitivity of T24-CR xenograft (Fig. 5A, B), while these two treatments showed a synergetic effect in reducing T24-CR xenograft tumor weight (Fig. 5C) and volume (Fig. 5D).